Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

NCT ID: NCT06851936Sponsor: University of FloridaLast updated: 2026-05-15

Summary

Given the challenges to delivering tobacco cessation treatment in oncology care and the unique challenges faced by individuals attempting to quit tobacco after a cancer diagnosis, scalable cessation programs that are tailored to the experiences of cancer survivors that also integrate caregiver/family support are needed. To address this need, this study will use an intervention that consists of two primary strategies: 1) a tailored cessation program for cancer survivors and family members/caregivers who use tobacco and 2) healthcare provider training. Healthcare providers will receive training on the AAC model (Ask patients about tobacco use, Advise patients to quit, Connect patients to cessation resources), including materials focused on tobacco cessation in cancer care from the CDC, as well as a brief evidence-based communication skills training based on the C-LEAR (Counsel, Listen, Empathize, Answer, Recommend) approach.

Arms & interventions

  • BehavioralNicotine cessation program

    All participants will complete a nicotine cessation program designed by Area Health Education Center (AHEC). The focus is on known tobacco cessation techniques and motivations to quit with additional focuses on cancer survivors and caregivers. The program consists of 4 sessions (each session is approximately 60 minutes long) that will be delivered by a Tobacco Treatment Specialist by either videoconference or by telephone. Dyad enrollees (i.e., cancer survivors and their caregiver/family member) will complete sessions together. Participants will also be eligible for free nicotine replacement therapy while on study if medically appropriate.

Outcome measures

Primary

  • Program reach for cancer survivors

    Determine the reach of the nicotine cessation program used in this study for cancer survivors. This is defined as the proportion of eligible patients enrolled (i.e., agreed to participate and consented) during the study period.

    Time frame: Baseline

Secondary

  • Program reach for caregivers/family members of cancer survivors

    Time frame: Baseline

  • Program effectiveness in tobacco cessation

    Time frame: Either 1 week after nicotine cessation program completion or 8 weeks after baseline assessment for participants who do not complete the program sessions

  • Program effectiveness in tobacco cessation

    Time frame: Either 3 months after nicotine cessation program completion or 5 months after baseline assessment for participants who do not complete the program sessions

  • Clinic-level adoption of the study intervention

    Time frame: 18 months

  • Healthcare provider-level adoption of the study intervention

    Time frame: 1-2 weeks

  • Participant satisfaction

    Time frame: Either 1 week after nicotine cessation program completion or 8 weeks after baseline assessment for participants who do not complete the program sessions

  • Participant adherence

    Time frame: 8 weeks after baseline assessment

  • Participant perspectives on program feasibility and acceptability

    Time frame: Up to 4 weeks after program completion

  • Healthcare provider perspectives on intervention feasibility and acceptability

    Time frame: 18 months

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: Yes
Inclusion Criteria: Cancer Survivors including Current Cancer Patients * Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month. * Any history of cancer diagnosis. Subjects currently receiving cancer-related treatments are eligible for enrollment. * Receiving care from the participating UF Health clinics (Medical Oncology, Urology, and Radiation Oncology). * Capable of completing study requirements * Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes * Adults aged ≥18 years Informal Caregivers/Family Members of Cancer Survivors * Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month. * A family member, informal caregiver, or friend of an enrolled cancer survivor receiving care from the participating UF Health clinics as described above * Capable of completing study requirements * Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes * Adults aged ≥18 years Exclusion Criteria: Cancer Survivors including Current Cancer Patients * Patients unable to complete the sessions because of language, travel or technology barriers * Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness. Informal Caregivers/Family Members of Cancer Survivors * Participants unable to complete the sessions because of language, travel or technology barriers * Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

Study locations (1)

University of Florida

Gainesville, Florida, 32608

Recruiting
Erika Barahona, M. Ed · Contact
352-273-7345ebarahona@ufl.edu
Jennifer LeLaurin, PhD · Principal Investigator
Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers | Cancerify